$AMRN upside targets, High risk , high reward pour NASDAQ:AMRN par RedHotStocks

trendanalysis chartpattern harmonicpatterns

MAy be a case that speculators are in the stock for a quick $$$ after a very erratic selloff.
Jefferies analyst Michael Yee is hosting a conference call with life sciences patent lawyer Jacob Sherkow, who said during the call that he believes Amarin has a 50% chance to win its appeal related to its recent loss in litigation related to generic versions of Vascepa.
Source TheFly.com

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.